Skip to content

Marc L Andreessen, 10% owner at Scribe Therapeutics, bought SCTX on Jul 27, 2026

Data as of Oct 16

▲ BUY$5M333,333 shares at $15.00Marc L Andreessen 10% ownerSCTX Scribe Therapeutics, Inc.
Watch SCTX
Traded
Jul 27, 2026
Disclosed
Jul 29, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Marc L Andreessen, 10% owner at Scribe Therapeutics, bought SCTX on Jul 27, 2026TRADEDDISCLOSED
SCTXSimilar stocks (XLV — its sector index fund), rebased to SCTX's price on the disclosure day
SCTX since disclosure
+9.4%
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Jul 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYAH Equity Partners Bio III, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  2. ▲ BUYAH Equity Partners Bio II, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  3. ▲ BUYAH Bio Fund III, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  4. ▲ BUYBenjamin A Horowitz 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  5. ▲ BUYAH Bio Fund II, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade

See every trade on SCTX →